Mariner Wealth Advisors »

Denali Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $844k 33k 25.72
2026-03-31 $348k 18k 19.20

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Broadcom (AVGO)
Ishares Tr Core S&p Mcp Etf (IJH)
Micron Technology (MU)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Mariner Wealth Advisors

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Goldman Sachs Group
Geode Capital Management
Holocene Advisors
Baker Bros. Advisors
Ubs Global Asset Management Americas
UBS Group
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Denali Therapeutics